FGF2 and neoplasm: In vivo studies found that Endostar inhibited tumor growth in nude mouse models of GC, reduced the expression of pro-angiogenic factors such as VEGF and basic fibroblast growth factor (bFGF), and induced tumor cell apoptosis [8-10].